ARYx Therapeutics, Inc. (ARYX) – StreetInsider.com Reports
-
Pre-Open Movers: (GMCR) (HGSI) (SBUX) Higher; (JTX) (CWTR) (PEET) Lower
-
ARYx (ARYX) trading to resume at 6pm ET
-
ARYx (ARYX) Says FDA Issued Prelim. Notification of Additional Delay for SPA on Naronapride; Co. Can No Longer Continue Operations
-
ARYx Therapeutics (ARYX) trading halted, news disseminated
-
ARYx Therapeutics (ARYX) Updates on NASDAQ Listing
-
ARYx Therapeutics (ARYX) To Begin Trading on NASDAQ Capital Market
-
Unusual 11 Mid-Day Movers 12/17: ITMN, NYMX, IBCP, PTX, MI, BBX Higher; FSBK, SMOD, RXII, WNI, ARYX Lower
-
Notable 52-Week Highs and Lows of the Day 12/17: ORCL, CBS, TTWO, ACN High; ARYX, CLWR, FSBK Low
-
Notable 52-Week Highs and Lows of the Day 12/16: MOT, CIEN, NDAQ, KEG High; ARYX, CMRO Low
-
ARYx Therapeutics (ARYX) Posts Q3 Loss of 8c, Narrower than Views
-
Wedbush Lowers Fair Value on ARYx Therapeutics (ARYX); New Equity and Debt Arrangements Extend Cash Runway to End of 2010
-
ARYx Therapeutics (ARYX) Announces $6.3M in New Financings
-
Trading Radar for 08/13: Lowe's (LOW), Sysco Corp. (SYY), RINO Int'l (RINO), Valspar (VAL),
-
Morning Movers 8/10: CCBP, RMX, ZSTN, QNST, DUCK, PSEM Higher; CYRX, SCLN, HQS, ABK, JAG, PEGA, AGM, ANSW, MR Lower
-
ARYx Therapeutics (ARYX) Files $50M Mixed Shelf
-
ARYx Therapeutics (ARYX) Posts Q4 Loss of $0.21, Narrower than Views
-
Oppenheimer Downgrades ARYx Therapeutics (ARYX) to Perform
-
Unusual 11 Mid-Day Movers 2/19: PIII, RAS, MHJ, NR, DRAM Higher; ARYX, ES, MMSI, ELGX Lower
-
Morning Movers 2/19: COBR, SII, COBK, RAS Higher; ARYX, ES, MMSI, CSIQ, SLXP, ACPW Lower
-
ARYx Therapeutics (ARYX) Announces Interest in Exploring Options
-
ARYx Therapeutics (ARYX) Receives U.S. FDA Guidance Regarding Anticoagulant Agent Tecarfarin
-
ARYx Therapeutics (ARYX) Announces Results from PASCAL Phase 2b
-
ARYx Therapeutics (ARYX) Experiences a Q3 Loss of $0.30, Misses Views
-
Trading Radar for 11/12: Wal-Mart (WMT), Blockbuster (BBI), Nordstrom (JWN), Walt Disney (DIS), Kohl's (KSS) Report
-
$35MM Financing Facility Secured by ARYx Therapeutics (ARYX)
-
Unusual 11 Mid-Day Movers 7/8: NVGN, GRVY, TRGT, AMGN Higher; ARYX, RODM, YRCW, GNW Lower
-
Morning Movers 7/8: TRGT, HNAB, AMGN, NTWK, FDO Higher; ARYX, XNPT, ARNA, AXL Lower
-
ARYx Therapeutics (ARYX) Whacked After Blood Clot Treatment Fails To Hit Primary Endpoint
-
Morning Movers 6/16: VOXW, EMKR, LZB, HOV, ALVR, MRNA Higher; SURG, AHT, FCEL Lower
-
ARYx Therapeutics (ARYX) Updates Progress with Tecarfarin EmbraceAC Study
-
Hapoalim Securities Initiates Coverage on ARYx Therapeutics (ARYX) with a Market Outperform
-
Trading Radar for 3/26: Best Buy (BBY), Texas Industries (TXI), Accenture (ACN), ConAgra (CAG), Dr Pepper Snapple (DPS), GameStop (GME) Report; Initial Claims, Final Q4 GDP Due
-
Unusual 11 Mid-Day Movers 12/18: ARYX, GIII, MU, XL Higher; CPY, ADLR, TTWO, SIMG Lower
-
Morning Movers 12/18: DVAX, ARYX, NOBH, AUXL Higher; CPY, TTWO, TNC, CVD Lower
-
ARYx Therapeutics (ARYX) Reports Results from Phase 2b Trial Testing ATI-2042
-
ARYx Therapeutics (ARYX) Reports Q3 EPS of $0.17
-
Pre-Open Movers 7/3: NVIDIA (NVDA) Clobbered On Warning, Chindex (CHDX) Up on China Approvals
-
After-Hours Movers 7/2: NVIDIA (NVDA) Slammed on Q2 Warning, ARYx (ARYX) Lower After P&G Walks From Partnership
-
ARYx (ARYX) Announces Successful Study Results But Procter & Gamble (PG) Ends Collaboration
-
CIBC Initiates Coverage on ARYx Therapeutics (ARYX) with an Outperform
-
Morgan Stanley Initiates Coverage on ARYx Therapeutics (ARYX) with an Overweight
-
ARYx Therapeutics (ARYX) Sees IPO Price of $10
-
ARYx Therapeutics (ARYX) IPO Trades Lower
-
ARYx Therapeutics (ARYX) Files $86.25 Million IPO
Back to ARYX Stock Lookup